Shares of Senseonics Holdings Inc (AMEX:SENS) have earned a consensus rating of “Buy” from the six brokerages that are presently covering the firm. One analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 12-month target price among analysts that have covered the stock in the last year is $5.50.

Several brokerages recently commented on SENS. B. Riley reissued a “buy” rating and set a $5.00 price objective on shares of Senseonics Holdings in a research report on Wednesday, November 9th. Canaccord Genuity reissued a “buy” rating and set a $6.00 price objective on shares of Senseonics Holdings in a research report on Wednesday, August 10th. Zacks Investment Research raised shares of Senseonics Holdings from a “sell” rating to a “hold” rating in a research report on Friday, November 18th. Finally, Leerink Swann reissued an “outperform” rating and set a $6.00 price objective (up from $4.50) on shares of Senseonics Holdings in a research report on Thursday, September 22nd.

Senseonics Holdings (AMEX:SENS) traded up 0.34% during trading on Friday, hitting $2.91. 66,135 shares of the stock traded hands. The firm has a 50-day moving average price of $2.78 and a 200 day moving average price of $3.49. The company’s market cap is $271.76 million. Senseonics Holdings has a 52-week low of $2.17 and a 52-week high of $4.24.

Senseonics Holdings (AMEX:SENS) last announced its quarterly earnings data on Thursday, November 3rd. The company reported ($0.12) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.11) by $0.01. On average, equities analysts expect that Senseonics Holdings will post ($0.51) EPS for the current year.

TRADEMARK VIOLATION NOTICE: “Senseonics Holdings Inc (SENS) Receives Consensus Rating of “Buy” from Analysts” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this news story on another website, it was illegally stolen and reposted in violation of international trademark and copyright law. The legal version of this news story can be read at https://www.thecerbatgem.com/2016/11/25/senseonics-holdings-inc-sens-receives-consensus-rating-of-buy-from-analysts.html.

Senseonics Holdings Company Profile

Senseonics Holdings, Inc, formerly ASN Technologies, Inc, is a medical technology company. The Company is focused on the design, development and commercialization of glucose monitoring systems. The Company operates through glucose monitoring systems segment. It offers a continuous glucose monitoring (CGM) system, Eversense, which is designed to be an implantable CGM system to continually measure glucose levels in people with diabetes for a period of approximately 90 days.

Receive News & Stock Ratings for Senseonics Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics Holdings Inc and related stocks with our FREE daily email newsletter.